Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice.

M L Hartoft-Nielsen1, A K Rasmussen, A Kaas

  • 1Department of Medical Endocrinology, Rigshospitalet, University Hospital of Copenhagen, Denmark. mhartoft@RH.DK

Autoimmunity
|March 27, 2001
PubMed
Summary

Linomide, an immunomodulator, did not prevent autoimmune thyroiditis (AIT) in non-obese diabetic (NOD) mice. This study found no significant difference in thyroiditis incidence between Linomide-treated and control NOD mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risks of suboptimal and excessive thyroid hormone replacement across ages.

Journal of endocrinological investigation·2023
Same author

Representational similarity scores of digits in the sensorimotor cortex are associated with behavioral performance.

Cerebral cortex (New York, N.Y. : 1991)·2022
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis.

JAMA·2019
Same author

THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY.

Acta endocrinologica (Bucharest, Romania : 2005)·2019
Same author

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide.

Endocrine·2018

Area of Science:

  • Immunology
  • Endocrinology
  • Pathology

Background:

  • Linomide is a potent immunomodulator with demonstrated efficacy in preventing type 1 diabetes mellitus in non-obese diabetic (NOD) mice.
  • Its proposed mechanisms include down-regulating macrophage activity and antagonizing Th1 cell activation in immune responses.
  • Previous studies suggest Linomide's potential in mitigating various autoimmune conditions in animal models.

Purpose of the Study:

  • To investigate the effect of Linomide on the incidence of spontaneous autoimmune thyroiditis (AIT) in female NOD mice.
  • To assess whether Linomide administration influences the development or severity of AIT in this model.

Main Methods:

  • Female NOD mice were administered Linomide (100 mg/kg/day) in drinking water from week 5 to 19 of age.

Related Experiment Videos

  • Thyroiditis incidence and severity were evaluated using HE-stained sections at week 19.
  • Statistical analysis (chi-squared test) was used to compare the incidence between treated and control groups.

    • Main Results:

    • None of the mice developed diabetes during the study period.
    • Thirty-two percent of Linomide-treated mice (37 total) developed thyroiditis compared to 45% of control mice (22 total).
    • No significant difference in thyroiditis incidence (p=0.31) or severity was observed between the groups.

    Conclusions:

    • Linomide administration did not demonstrate a beneficial effect on the incidence or severity of spontaneous autoimmune thyroiditis in female NOD mice.
    • The immunomodulatory effects of Linomide may not extend to preventing autoimmune thyroiditis in this specific NOD mouse model.
    • Further research is needed to elucidate Linomide's role in autoimmune disease prevention and its mechanisms of action.